Severe flare of generalized pustular psoriasis treated with spesolimab, an IL-36-directed monoclonal antibody

J Dtsch Dermatol Ges. 2024 May;22(5):696-699. doi: 10.1111/ddg.15334. Epub 2024 Apr 15.

Authors

Valeria Mateeva¹, Preslav Vasilev², Klimentina Gospodinova², Veronika Gincheva², Martin Shahid¹, Polina Kostova³, Tsvetan Lukanov⁴, Ivelina Yordanova²

Affiliations

¹ Department of Dermatology and Venereology, Faculty of Medicine, Medical University - Sofia, Sofia, Bulgaria.
² Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University Pleven, Pleven, Bulgaria.
³ Department of Pediatrics, Faculty of Medicine, Medical University Sofia, Sofia, Bulgaria.
⁴ Department of Clinical Immunology and Allergology, Faculty of Healthcare, Medical University Pleven, Pleven, Bulgaria.

PMID: 38619312
DOI: 10.1111/ddg.15334

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Female
Humans
Interleukins
Male
Middle Aged
Psoriasis* / drug therapy
Treatment Outcome

Substances

Interleukins
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal

Grants and funding

Boehringer Ingelheim RCV GmbH & Co KG